Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Programmable hydraulic resistor for microfluidic chips using electrogate arrays.

Salva ML, Temiz Y, Rocca M, Arango YC, Niemeyer CM, Delamarche E.

Sci Rep. 2019 Nov 21;9(1):17242. doi: 10.1038/s41598-019-53885-w.

2.

Histogenesis and Histomorphometric study of Human Fetal Small Intestine.

Salva MN, Gupta C, Pandey AK, Kumar N, Kotian SR, Kalthur SG.

Ethiop J Health Sci. 2019 Nov;29(6):689-696. doi: 10.4314/ejhs.v29i6.5.

3.

Flow and airway pressure analysis for detecting ineffective effort during mechanical ventilation in neuromuscular patients.

Ciorba C, Gonzalez-Bermejo J, Salva MQ, Annane D, Orlikowski D, Lofaso F, Prigent H.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318790267. doi: 10.1177/1479972318790267. Epub 2018 Jul 31.

4.

Fatal Disseminated Kaposi's Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection.

Fardin RB, Leite LAC, Bezerra LMDS, Alves PMP, Dos Santos LL, Salvá MA, Rezende Filho ALSM, Lima GS, Matos JA, Ferreira SMS, Costa DLJF.

Am J Case Rep. 2018 Jul 25;19:868-874. doi: 10.12659/AJCR.910004.

5.

Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.

Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, Lucato P, Gomiero W, Garelli S, Sabbadin C, Salvà M, Costa MD, Boscaro M, Luisetto G.

Endocrine. 2018 Feb;59(2):319-329. doi: 10.1007/s12020-017-1380-8. Epub 2017 Aug 9.

PMID:
28795340
6.

The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells.

Pezzani R, Rubin B, Redaelli M, Radu C, Barollo S, Cicala MV, Salvà M, Mian C, Mucignat-Caretta C, Simioni P, Iacobone M, Mantero F.

Endocr J. 2014;61(1):41-53. Epub 2013 Oct 24.

7.

Addison's disease: a survey on 633 patients in Padova.

Betterle C, Scarpa R, Garelli S, Morlin L, Lazzarotto F, Presotto F, Coco G, Masiero S, Parolo A, Albergoni MP, Favero R, Barollo S, Salvà M, Basso D, Chen S, Rees Smith B, Furmaniak J, Mantero F.

Eur J Endocrinol. 2013 Oct 21;169(6):773-84. doi: 10.1530/EJE-13-0528. Print 2013 Dec.

PMID:
24014553
8.

Accurate in vitro identification of fracture onset in bones: failure mechanism of the proximal human femur.

Juszczyk MM, Cristofolini L, Salvà M, Zani L, Schileo E, Viceconti M.

J Biomech. 2013 Jan 4;46(1):158-64. doi: 10.1016/j.jbiomech.2012.11.013. Epub 2012 Dec 4.

PMID:
23218142
9.

Multiparametric immunotoxicity screening in mice during early drug development.

Aulí M, Domènech A, Andrés A, Orta M, Salvà M, Descotes J, Prats N.

Toxicol Lett. 2012 Oct 17;214(2):200-8. doi: 10.1016/j.toxlet.2012.08.020. Epub 2012 Aug 31.

PMID:
22944472
10.

Primary aldosteronism: the role of confirmatory tests.

Salvà M, Cicala MV, Mantero F.

Horm Metab Res. 2012 Mar;44(3):177-80. doi: 10.1055/s-0032-1304661. Epub 2012 Mar 6. Review.

PMID:
22395800
11.

Characterization of in vitro metabolic profiles of cinitapride obtained with liver microsomes of humans and various mammal species using UHPLC and chemometric methods for data analysis.

Marquez H, Albertí J, Salvà M, Saurina J, Sentellas S.

Anal Bioanal Chem. 2012 May;403(4):909-16. doi: 10.1007/s00216-012-5795-z. Epub 2012 Feb 24.

PMID:
22362276
12.

Development of a UHPLC method for the assessment of the metabolic profile of cinitapride.

Marquez H, Albertí J, Salvà M, Saurina J, Sentellas S.

J Sep Sci. 2011 Dec;34(24):3502-8. doi: 10.1002/jssc.201100073. Epub 2011 Jun 22.

PMID:
21695682
13.

In vitro liver metabolism of aclidinium bromide in preclinical animal species and humans: identification of the human enzymes involved in its oxidative metabolism.

Albertí JJ, Sentellas S, Salvà M.

Biochem Pharmacol. 2011 Mar 15;81(6):761-76. doi: 10.1016/j.bcp.2010.12.013. Epub 2010 Dec 22.

PMID:
21184745
14.

Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide.

Albertí J, Martinet A, Sentellas S, Salvà M.

Drug Metab Dispos. 2010 Jul;38(7):1202-10. doi: 10.1124/dmd.109.031724. Epub 2010 Mar 23.

PMID:
20332199
15.

Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites.

Sentellas S, Ramos I, Albertí J, Salvà M, Antón F, Miralpeix M, Beleta J, Gavaldà A.

Eur J Pharm Sci. 2010 Mar 18;39(5):283-90. doi: 10.1016/j.ejps.2010.01.004. Epub 2010 Jan 20. Review.

PMID:
20093184
16.

Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO).

Mesquita F, Jacka D, Ricard D, Shaw G, Tieru H, Hu Y, Poundstone K, Salva M, Fujita M, Singh N.

Harm Reduct J. 2008 Aug 5;5:26. doi: 10.1186/1477-7517-5-26.

17.

Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.

Sun B, Young SP, Li P, Di C, Brown T, Salva MZ, Li S, Bird A, Yan Z, Auten R, Hauschka SD, Koeberl DD.

Mol Ther. 2008 Aug;16(8):1366-71. doi: 10.1038/mt.2008.133. Epub 2008 Jun 17.

18.

The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.

Robert M, Salvà M, Segarra R, Pavesi M, Esbri R, Roberts D, Golor G.

Drug Metab Dispos. 2007 Jul;35(7):1149-56. Epub 2007 Apr 16.

PMID:
17437965
19.

Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.

Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, Finn EE, Nguyen QG, Blankinship MJ, Meuse L, Chamberlain JS, Hauschka SD.

Mol Ther. 2007 Feb;15(2):320-9.

20.
21.

Disposition and metabolism of almotriptan in rats, dogs and monkeys.

Aubets J, Cardenas A, Salva M, Jansat JM, Martinez-Tobed A, Palacios JM.

Xenobiotica. 2006 Sep;36(9):807-23.

PMID:
16971345
22.

Pharmacokinetics and safety of oral almotriptan in healthy male volunteers.

McEwen J, Salva M, Jansat JM, Cabarrocas X.

Biopharm Drug Dispos. 2004 Oct;25(7):303-11.

PMID:
15386481
23.

Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan.

Salva M, Jansat JM, Martinez-Tobed A, Palacios JM.

Drug Metab Dispos. 2003 Apr;31(4):404-11.

PMID:
12642466
24.

Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment.

Burgos FJ, Salvà M, Villegas V, Soriano F, Mendez E, Avilés FX.

Biochemistry. 1991 Apr 23;30(16):4082-9.

PMID:
2018774
25.

Lipid peroxidation in rat cerebral cortex during post-ischemic reperfusion: effect of exogenous antioxidants and Ca(++)-antagonist drugs.

Vanella A, Sorrenti V, Gambera G, Castorina C, Di Giacomo C, Campisi A, Salva M, Perez-Polo JR.

Ital J Biochem. 1990 May-Jun;39(3):196A-198A. No abstract available.

PMID:
2391232
26.

Generation of a subunit III-like protein by autolysis of human and porcine proproteinase e in a binary complex with procarboxypeptidase A.

Avilés FX, Pascual R, Salva M, Bonicel J, Puigserver A.

Biochem Biophys Res Commun. 1989 Sep 29;163(3):1191-6.

PMID:
2675835
28.

Purification and properties of five different forms of human procarboxypeptidases.

Pascual R, Burgos FJ, Salva M, Soriano F, Mendez E, Aviles FX.

Eur J Biochem. 1989 Feb 15;179(3):609-16.

29.

Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia.

Salva MA, Guilleminault C.

Neurology. 1986 Apr;36(4):576-7.

PMID:
3960336
30.

Viloxazine hydrochloride in narcolepsy: a preliminary report.

Guilleminault C, Mancuso J, Salva MA, Hayes B, Mitler M, Poirier G, Montplaisir J.

Sleep. 1986;9(1 Pt 2):275-9.

PMID:
3704453
31.

Narcolepsy, cataplexy, heart rate, and blood pressure.

Guilleminault C, Salva MA, Mancuso J, Hayes B.

Sleep. 1986;9(1 Pt 2):222-6.

PMID:
3704446
32.

Daytime sleep characteristics and their relationships with night sleep in the narcoleptic patient.

Billiard M, Salva MQ, De Koninck J, Besset A, Touchon J, Cadilhac J.

Sleep. 1986;9(1 Pt 2):167-74.

PMID:
3704438
33.

Are REM cycles in narcoleptic patients governed by an ultradian rhythm?

De Koninck J, Salva MQ, Besset A, Billiard M.

Sleep. 1986;9(1 Pt 2):162-6.

PMID:
3704437
34.

Visceral leishmaniasis in kidney transplantation: report of one case.

Salva M, Fernandez Fernandez J, Berisa F, Enriquez R, Sanz Moreno C, Sanz Guajardo D, Gallego JL, Hernandez J, Botella J.

Clin Transpl. 1986:134. No abstract available.

PMID:
3154385
35.

[Cytomegalovirus infection in a seronegative patient with a transplanted kidney].

Sanz Moreno C, Enríquez R, Salvá M, Berisa F, Fernández Fernández J, Botella J.

Med Clin (Barc). 1984 Apr 21;82(15):692. Spanish. No abstract available.

PMID:
6330466
36.

[Acute interstitial nephritis caused by erythromycin].

Enríquez R, Berisa F, Sanz Moreno C, Salvá M, Sanz Guajardo D, Fernández Fernández J, Gallego JL, Botella J.

Med Clin (Barc). 1984 Feb 4;82(4):182-3. Spanish. No abstract available.

PMID:
6708630

Supplemental Content

Support Center